血清总胆红素水平与初级皮肤冠状动脉干预后的对比诱导脏病相关
Murat Oğuz Özilhan1, Sadık Kadri Açıkgöz1
1Department of Cardiology, Ankara City Hospital, Ankara, Turkey.
Angiology
|June 27, 2023
概括
较低的血清胆红素水平与接受初级皮肤冠状动脉干预 (pPCI) 的ST段升高心肌梗塞 (STEMI) 患者的对比诱导脏病 (CIN) 风险更高有关. 胆红素可以作为CIN的预测生物标志物.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
背景情况:
- 对比诱导性脏病 (CIN) 是血管造影手术,特别是ST段升高心肌梗塞 (STEMI) 的初级穿皮冠状动脉干预 (pPCI) 后的严重并发症.
- 氧化应激和自由基损伤与CIN.的病变发生有关.
- 胆红素具有抗氧化和抗炎性质,为内皮细胞提供潜在的保护.
研究的目的:
- 调查血清总胆红素水平与接受pPCI的STEMI患者中CIN发生率之间的关联.
主要方法:
- 分析了在2021年1月至2022年12月期间接受pPCI的595名STEMI患者的队列.
- 测量了血清总胆固醇水平,并记录了CIN的发展.
- 使用多变量逻辑回归分析来确定CIN的独立预测因子.
主要成果:
- 116名患者 (19.5%) 发生了CIN.
- 在患有CIN (P = .001) 的患者中,血清总胆红素水平显著降低 (P = .001).
- 较低的血清胆红素水平被确定为CIN的独立预测因子,与年龄,性别,对比度体积和白细胞计数一起.
结论:
- 血清胆红素水平升高与接受pPCI的STEMI患者中发展CIN的风险降低有关.
- 血清胆红素可以作为一个有价值的生物标志物来预测CIN风险.
- 监测胆红素水平可以帮助早期预防策略和对CIN的患者随访.
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
73
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
73
Serum Studies: Renal Function Tests
24
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
24
Acute Kidney Injury IV: Diagnostic Studies and Prevention
40
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
40
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
127
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
127
Acute Coronary Syndrome III: Diagnostic Studies
11
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
204
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
204


